NR1H4 | Nuclear receptor subfamily 1, group H, member 4 | Nuclear receptors Transcription factors
| | | | | Tissue enhanced |
OGDHL | Oxoglutarate dehydrogenase-like | Citric acid cycle related proteins Mitochondrial proteins
| | | | | Tissue enhanced |
ONECUT1 | One cut homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
OSGIN1 | Oxidative stress induced growth inhibitor 1 | | | | | | Tissue enhanced |
OXT | Oxytocin/neurophysin I prepropeptide | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PAH | Phenylalanine hydroxylase | Disease related genes Enzymes FDA approved drug targets
| | | | | Tissue enhanced |
PANK1 | Pantothenate kinase 1 | Enzymes
| | | | | Tissue enhanced |
PAQR9 | Progestin and adipoQ receptor family member IX | Predicted membrane proteins
| | | | | Tissue enhanced |
PCK1 | Phosphoenolpyruvate carboxykinase 1 (soluble) | Citric acid cycle related proteins Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
PCSK6 | Proprotein convertase subtilisin/kexin type 6 | Enzymes
| | | | | Tissue enhanced |
PCSK9 | Proprotein convertase subtilisin/kexin type 9 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
PKLR | Pyruvate kinase, liver and RBC | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
PLA1A | Phospholipase A1 member A | Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PLCXD2 | Phosphatidylinositol-specific phospholipase C, X domain containing 2 | | | | | | Tissue enhanced |
PNPLA3 | Patatin-like phospholipase domain containing 3 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
PROS1 | Protein S (alpha) | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PROX1 | Prospero homeobox 1 | Plasma proteins Transcription factors
| | | | | Tissue enhanced |
PSAT1 | Phosphoserine aminotransferase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
RBP5 | Retinol binding protein 5, cellular | Plasma proteins
| | | | | Tissue enhanced |
REEP6 | Receptor accessory protein 6 | Predicted membrane proteins
| | | | | Tissue enhanced |
RELN | Reelin | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
RND1 | Rho family GTPase 1 | Cytoskeleton related proteins
| | | | | Tissue enhanced |
RP11-10A14.4 | Uncharacterized protein | Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-407N17.3 | CTAGE family member 5 isoform 4 | Predicted membrane proteins
| | | | | Tissue enhanced |
RP11-422N16.3 | Uncharacterized protein | | | | | | Tissue enhanced |
RP11-986E7.7 | | | | | | | Tissue enhanced |
SEC14L2 | SEC14-like 2 (S. cerevisiae) | | | | | | Tissue enhanced |
SEC14L3 | SEC14-like 3 (S. cerevisiae) | Predicted secreted proteins
| | | | | Tissue enhanced |
SERPINA4 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 4 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SERPINA5 | Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SERPINE1 | Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SHBG | Sex hormone-binding globulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLC10A5 | Solute carrier family 10, member 5 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC16A13 | Solute carrier family 16, member 13 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC22A3 | Solute carrier family 22 (organic cation transporter), member 3 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC25A15 | Solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15 | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC30A10 | Solute carrier family 30, member 10 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC6A12 | Solute carrier family 6 (neurotransmitter transporter), member 12 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC7A2 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
STEAP3 | STEAP family member 3, metalloreductase | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
SULT2A1 | Sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | Enzymes
| | | | | Tissue enhanced |
THRSP | Thyroid hormone responsive | | | | | | Tissue enhanced |
TMEM56 | Transmembrane protein 56 | Predicted membrane proteins
| | | | | Tissue enhanced |
TMEM56-RWDD3 | TMEM56-RWDD3 readthrough | Predicted membrane proteins
| | | | | Tissue enhanced |
TMPRSS9 | Transmembrane protease, serine 9 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
TRIM55 | Tripartite motif containing 55 | Predicted membrane proteins
| | | | | Tissue enhanced |
TSKU | Tsukushi, small leucine rich proteoglycan | Predicted secreted proteins
| | | | | Tissue enhanced |
TSLP | Thymic stromal lymphopoietin | Predicted secreted proteins
| | | | | Tissue enhanced |
UGT1A6 | UDP glucuronosyltransferase 1 family, polypeptide A6 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
UGT1A8 | UDP glucuronosyltransferase 1 family, polypeptide A8 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |